Stockreport

Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement

Cara Therapeutics, Inc.  (CARA) 
Last cara therapeutics, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.caratherapeutics.com/investor-relations
PDF Proposed Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company developing novel treatments targeting STAT3 to treat fibrosis-driven diseases [Read more]